Roher, Alex E.
Kokjohn, Tyler A.
Clarke, Steven G.
Sierks, Michael R. http://orcid.org/0000-0001-7301-230X
Maarouf, Chera L.
Serrano, Geidy E.
Sabbagh, Marwan S.
Beach, Thomas G.
Funding for this research was provided by:
Astra Seneca
Avid Pharmaceuticals
Axovant
Genentech Inc.
Lilly Pharmaceuticals
Merck and Co.
Pfizer
Roche Diagnostics Corp.
vTv Therapeutics and Piramal Imaging
National Institutes of Health
Michael J. Fox Foundation for Parkinson's Research
State of Arizona
The National Institute on Aging (R01 AG019795)
Midwestern University, Glendale
Life Extension Foundation, Inc
Elizabeth and Thomas Plott Chair in Gerontology of the UCLA Longevity Center
Arizona Alzheimer's Disease Consortium
Department of Defense (W81XWH-14-1-0467)
National Institute of Neurological Disorders and Stroke (U24 NS072026)
National Institute on Aging (P30 AG19610)
Arizona Department of Health Services (211002)
Arizona Biomedical Research Commission (4001, 0011, 05-901, 1001)
Michael J. Fox Foundation for Parkinson's Research
This article is maintained by: Elsevier
Article Title: APP/Aβ structural diversity and Alzheimer's disease pathogenesis
Journal Title: Neurochemistry International
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.neuint.2017.08.007
Content Type: article
Copyright: © 2017 Elsevier Ltd. All rights reserved.